bioRxivCell Biology
The Parkinson's Disease related mutant VPS35 (D620N) amplifies the LRRK2 response to endolysosomal stress
K. R. McCarron, H. Elcocks, H. J. Mortiboys, S. Urbe, M. J. Clague
Abstract
The identification of multiple genes linked to Parkinsons Disease invites the question as to how they may cooperate. We have generated isogenic cell lines that inducibly express either wild-type or a mutant form of the retromer component VPS35 (D620N), which has been linked to Parkinsons Disease. This has enabled us to test proposed effects of this mutation in a setting where the relative expression reflects the physiological occurrence. We confirm that this mutation compromises VPS35 association with the WASH complex, but find no defect in WASH recruitment to endosomes, nor in the distribution of lysosomal receptors, cation-independent mannose-6-phosphate receptor and Sortilin. We show VPS35 (D620N) enhances the activity of the Parkinsons associated kinase LRRK2 towards RAB12 under basal conditions. Furthermore, VPS35 (D620N) amplifies the LRRK2 response to endolysosomal stress resulting in enhanced phosphorylation of RABs 10 and 12. By comparing different types of endolysosomal stresses such as the ionophore nigericin and the membranolytic agent LLOMe, we are able to dissociate phospho-RAB accumulation from membrane rupture.
- organism: human
- assay: proteomics
- research focus: cell signaling & trafficking
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Parkinsons VPS35 mutation induces LRRK2 mediated lysosomal association of RILPL1 and TMEM55B
Prosenjit Pal, Matthew Taylor, … Dario R. Alessi·Science AdvancesPeer-reviewed·Dec 13, 2023
- Surface GluA1 and glutamate transmission are increased in VPS35 D620N neurons and altered by LRRK2 kinase inhibition
Chelsie Kadgien, Anusha Kamesh, … Austen J. Milnerwood·Molecular BrainPeer-reviewed·Sep 16, 2021
- Emergent glutamate & dopamine dysfunction in VPS35(D620N) knock-in mice and rapid reversal by LRRK2 inhibition
Anusha Kamesh, Chelsie Kadgien, … Austen J. Milnerwood·npj Parkinson s DiseasePeer-reviewed·May 3, 2025
- Parkinson's disease-linked D620N mutation selectively alters the brain-specific protein interactome of VPS35
Erin T. Williams, Maxwell A. Frye, … Darren J. Moore·Neurobiology of DiseasePeer-reviewed·Sep 1, 2026
- Inhibition of LRRK2 kinase activity rescues deficits in striatal dopamine dynamics in VPS35 p.D620N knock-in mice
Mengfei Bu, Jordan Follett, … Matthew James Farrer·bioRxiv·May 14, 2023
- Vps35 p.D620N causes Lrrk2 kinase hyperactivity, chronic microglial activation and inflammation
Isaac Bul Deng, Mengfei Bu, … Matthew James Farrer·bioRxiv·Sep 3, 2026